Journal of Zhejiang University-SCIENCE B
Scope & Guideline
Charting New Territories in Biochemistry and Toxicology
Introduction
Aims and Scopes
- Biomedical Research:
The journal emphasizes studies that address biomedical challenges, including cancer, cardiovascular diseases, neurodegenerative disorders, and infectious diseases, utilizing both experimental and computational approaches. - Stem Cell and Regenerative Medicine:
A significant focus is placed on stem cell research and therapies, exploring their potential applications in regenerative medicine and tissue engineering. - Nanotechnology and Materials Science:
The journal features research on the synthesis and application of nanomaterials in medicine, including drug delivery systems and biosensors, highlighting innovative engineering techniques. - Genomics and Molecular Biology:
Research in genomics, particularly studies utilizing CRISPR technology, RNA sequencing, and bioinformatics, is a core area, aiming to unravel the genetic underpinnings of diseases. - Environmental and Agricultural Sciences:
The journal also covers research on the interactions between health, agriculture, and the environment, including studies on microbiomes and plant health.
Trending and Emerging
- CRISPR and Genome Editing Technologies:
There has been a significant increase in studies utilizing CRISPR technology for gene editing, reflecting its growing relevance in genetic research and therapeutic applications. - Microbiome Research:
Research exploring the human and environmental microbiomes and their implications for health and disease is gaining traction, highlighting the interconnectedness of microbiota and overall wellbeing. - Artificial Intelligence and Machine Learning in Healthcare:
The integration of AI and machine learning techniques in medical research and diagnostics is emerging as a prominent theme, indicating a shift towards data-driven approaches in healthcare. - Regenerative Medicine and Tissue Engineering:
The focus on regenerative medicine, particularly using stem cells and biomaterials for tissue repair and regeneration, is trending upward, demonstrating the journal's commitment to innovative therapeutic strategies. - Personalized Medicine and Pharmacogenomics:
An increasing number of studies are addressing personalized medicine approaches, particularly in cancer treatment, emphasizing the importance of tailoring therapies based on individual genetic profiles.
Declining or Waning
- Traditional Chinese Medicine:
While traditional medicine has been a significant topic in past issues, recent publications reflect a decline in studies specifically focused on traditional Chinese medicinal practices and their applications. - Animal Models in Research:
There is a noticeable reduction in studies utilizing classical animal models for biomedical research, possibly reflecting a trend toward more advanced in vitro or computational modeling approaches. - Basic Science without Clinical Relevance:
The journal seems to be moving away from purely basic science studies that lack direct clinical implications, favoring research that demonstrates clear translational potential.
Similar Journals
Cells
Unlocking the Secrets of Life at the Cellular LevelCells, published by MDPI in Switzerland, is a leading open-access journal that has been disseminating groundbreaking research in the fields of Biochemistry, Genetics, and Molecular Biology since its inception in 2011. With an impressive E-ISSN of 2073-4409, the journal boasts a strong impact factor and ranks in the 84th percentile for Scopus ratings, underscoring its significance in advancing scientific knowledge. As a Q1-ranked journal in both 2023 and 2020, it serves as a premier platform for researchers, professionals, and students eager to explore innovative findings and methodologies. By providing unrestricted access to high-quality research, Cells plays a pivotal role in facilitating collaboration and inspiration within the global scientific community, making it an indispensable resource for anyone interested in cutting-edge discoveries in cellular biology.
Advanced Science
Leading the Charge in Multidisciplinary DiscoveriesAdvanced Science, published by Wiley, stands as a premier open-access journal since 2014, dedicated to fostering innovative research and insights across multiple disciplines including Biochemistry, Genetics and Molecular Biology, Chemical Engineering, Engineering, Materials Science, Medicine, and Physics and Astronomy. Based in Germany, this journal has quickly established itself in the academic community, receiving high recognition with a Q1 ranking in its respective categories as of 2023. With its impressive Scopus rankings, including #1 in Biochemistry, Genetics and Molecular Biology and #3 in General Engineering, Advanced Science plays a pivotal role in disseminating groundbreaking scientific knowledge to researchers, professionals, and students alike. By embracing an open access model, it ensures that high-quality research is readily available to a global audience, thus facilitating advancements in science and engineering fields.
Acta Naturae
Pioneering Insights in Biochemistry and BiotechnologyActa Naturae is a peer-reviewed scientific journal published by the Russian Federation Agency for Science & Innovation, focusing on the dynamic fields of Biochemistry, Biotechnology, Molecular Biology, and Molecular Medicine. Launched in 2013, the journal has established a solid reputation in the academic community, with its articles contributing to essential advancements and discussions within these disciplines. By 2023, it has achieved notable rankings—including Q2 status in Biotechnology and Q3 in Biochemistry, Molecular Biology, and Molecular Medicine—indicating its growing influence and relevance in the scientific literature. While currently operating under a non-open access model, Acta Naturae invites researchers, professionals, and students to engage with its comprehensive research reports and reviews that span the breadth of molecular life sciences. With the aim of facilitating scientific dialogue and innovation, this journal serves as a key resource for those seeking to stay at the forefront of molecular research.
Annual Review of Biomedical Engineering
Catalyzing Interdisciplinary Insights in Biomedical EngineeringAnnual Review of Biomedical Engineering, published by Annual Reviews, stands as a leading academic journal dedicated to the rapidly evolving field of biomedical engineering. With an impressive impact factor that reflects its high citation rates and rigorous peer-review process, this journal offers critical insights by synthesizing cutting-edge advancements and applications in both biomedical engineering and miscellaneous medicine. The journal, which is available in both print (ISSN: 1523-9829) and electronic formats (E-ISSN: 1545-4274), serves as an essential resource for researchers, professionals, and students aiming to stay abreast of significant developments and emerging trends. As of 2023, it is recognized in the top tier (Q1) for both Biomedical Engineering and Medicine, showcasing its esteemed position within the academic community, reflected in its high Scopus rankings. Spanning from 1999 to 2024, the Annual Review of Biomedical Engineering continues to catalyze interdisciplinary collaboration and innovation at the intersection of engineering and healthcare.
Epigenomes
Illuminating the Pathways of Epigenetic MechanismsEpigenomes is a distinguished open access journal published by MDPI, dedicated to advancing the field of epigenetics and its interdisciplinary connections to biochemistry, genetics, and molecular biology. Since its inception in 2017, this journal has provided a transparent platform for researchers to share their findings, contributing to a deeper understanding of epigenetic mechanisms and their implications in health, toxicology, and mutagenesis. Ranked in the Q2 quartile across multiple categories, including biochemistry and genetics, Epigenomes is recognized for its scholarly contributions, reflected in its notable Scopus rankings. Readers benefit from a wealth of open access articles, fostering innovation and collaboration within the academic community. With its headquarters in Switzerland and an unwavering commitment to scientific rigor, Epigenomes is positioned as a vital resource for researchers, professionals, and students seeking to deepen their insights into the epigenomic landscape.
Biology Direct
Unlocking the frontiers of biological research.Biology Direct is a leading open-access journal published by BMC, dedicated to disseminating groundbreaking research in the fields of biological sciences. Since its inception in 2006, the journal has emerged as a pivotal platform for scholars, researchers, and practitioners, providing unrestricted access to high-quality, peer-reviewed articles that cover a wide spectrum of topics, including biochemistry, ecology, and applied mathematics. With an impressive ranking in the first quartile across multiple scientific categories, including Agricultural and Biological Sciences and Biochemistry, Genetics, and Molecular Biology, Biology Direct is recognized for its rigorous standards and impactful contributions within the academic community. The journal's open-access model ensures that research findings reach a global audience, fostering collaboration and innovation. Researchers and students looking to stay ahead in the rapidly evolving biological sciences will find Biology Direct an invaluable resource for knowledge and insight.
MOLECULAR AND CELLULAR BIOCHEMISTRY
Exploring Cellular Processes with PrecisionMOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.
Tissue Engineering Part B-Reviews
Transforming Insights into Impactful Tissue Engineering.Tissue Engineering Part B-Reviews is a premier academic journal published by MARY ANN LIEBERT, INC, focusing on the interdisciplinary field of tissue engineering and regenerative medicine. With an impressive impact factor that places it in the Q1 category across multiple relevant fields—including Biochemistry, Bioengineering, Biomaterials, and Biomedical Engineering—this journal provides a vital platform for researchers and professionals to disseminate cutting-edge findings and comprehensive reviews. Covering a vast scope from 2008 to 2024, the journal is committed to advancing knowledge in the application of engineering principles to biological tissues, making it an indispensable resource for those at the forefront of biomedical innovation. While the journal does not currently offer open access options, its rigorous peer review process ensures high-quality contributions that are essential for academic and practical advancements. The journal's rankings in Scopus reflect its significance, catering to a diverse audience of students, researchers, and practitioners seeking the latest insights in this dynamic field.
Journal of Biological Engineering
Exploring the Intersection of Biology and EngineeringJournal of Biological Engineering, published by BMC, stands as a prominent Open Access journal since 2007, dedicated to advancing the interdisciplinary field of biological engineering. With an ISSN of 1754-1611, this UK-based journal aims to provide a platform for researchers and professionals to disseminate innovative and impactful research across various domains including Biomedical Engineering, Environmental Engineering, Cell Biology, and Molecular Biology. The journal's notable rankings in the 2023 category quartiles exemplify its position within the scientific community, featuring Q2 status in Biomedical Engineering and Environmental Engineering, along with Q3 in Cell Biology and Q2 in Molecular Biology. By maintaining robust Scopus rankings and ensuring free access to cutting-edge research, the Journal of Biological Engineering plays a crucial role in driving discovery and collaboration among scholars, thereby enriching both the academic landscape and applied sciences.
Acta Biomaterialia
Elevating Knowledge in Biomaterials and BeyondActa Biomaterialia, published by Elsevier Science Ltd, is a leading journal in the fields of biochemistry, biomaterials, biomedical engineering, biotechnology, and molecular biology. With an ISSN of 1742-7061 and an E-ISSN of 1878-7568, this prestigious journal has secured a remarkable position in the academic community, evidenced by its inclusion in the Q1 category across multiple disciplines for 2023. It ranks impressively at #21 in biochemistry, #16 in biomedical engineering, #18 in biotechnology, and #11 in biomaterials, reflecting its high impact and relevance to ongoing research and development. The journal provides a platform for disseminating innovative research and advancements in the design and application of biomaterials, contributing to scientific discussions that propel the field forward. Although it does not currently offer open access options, Acta Biomaterialia continues to attract contributions that advance our understanding of biomaterials and their interactions with biological systems, ensuring that researchers, professionals, and students remain informed about the latest trends and breakthroughs in this rapidly evolving area of study.